Use of the Perclose ProGlide Closure Device to Remove a Central Venous Catheter Inadvertently Inserted in the Right Subclavian Artery

Similar documents
Vascular Closure Techniques

Vascular Closure Device: A to Z. Owayed M Al Shammeri, MD, FSCAI Interventional Cardiologist AlRayyan Hospital, HMG Riyadh

Volume 2 (2016) Issue 7 ISSN Abstract. Keywords access, catheter, coronary artery disease, radial, transradial, ulnar.

Access Closure: Manual vs. Device

Successful percutaneous treatment of late-onset femoral pseudoaneurysm after transcatheter, aortic valve implantation procedure

Experience with percutaneous suture system for larger caliber vascular access Bruno Freitas, Prof., MD

Vascular Closure Techniques

Vascular Closure Techniques

Copyright HMP Communications

Edwards Sapien. Medtronic CoreValve. Inoperable FDA approved High risk: in trials. FDA approved

Cordis EXOSEAL Vascular Closure Device

CLOSES WITH SECURITY. LEAVES WITHOUT A TRACE.

12-month results of a novel large access closure device: insights from the FRONTIER II Study

Originally Posted: November 15, 2014 BRUIT IN THE GROIN

Vascular Access: Management of Complications. Chris Burrell, South West Cardiothoracic Centre, Plymouth

Current Non-Surgical Cardiac Interventions. By Pam Bayles, RN, BSN

Optimal Techniques for Obtaining Large Caliber Arterial Access

Clinical Outcomes Among Vascular Procedure Patients Receiving Suture-mediated vs Surgical Cutdown for Closure of Large-bore Arterial Access

How to manage TAVI related vascular complications. Paul TL Chiam MBBS, FRCP, FESC, FACC, FSCAI

Copyright HMP Communications

Arterial Access for Diagnosis and Intervention T-Woei Tan, MD, FACS

Chronic total occlusions (CTOs)

Management of Inadvertent Carotid Artery Sheath Insertion During Central Venous Catheter Placement

1 Description. 2 Indications. 3 Warnings ASPIRATION CATHETER

DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service

The clinical benefit of percutaneous intervention

Alternate Vascular Access for TAVR. Gian Paolo Ussia Campus Bio-medico University, Rome Italy

Femoral Closure Devices: Good, Bad and Ugly. Zoltan G. Turi, M.D. Rutgers Robert Wood Johnson Medical School New Brunswick, NJ

Case Report Hemostasis of Left Atrial Appendage Bleed With Lariat Device

IMAGES. in PAEDIATRIC CARDIOLOGY

Issam M. Kably, MD; Dmitriy Meshkov, MD From University of Miami Miller School of Medicine/Jackson Memorial Hospital, Miami, Florida.

Tasopoulou KM 1, Argyriou C 1, Mantatzis M 2, Kantartzi K 3, Passadakis P 3, Georgiadis GS 1

Diagnosis and Management of Femoral Access Site Complications IV: Novel Techniques for Endovascular Rescue

Case Report Rapid Switch from Intra-Aortic Balloon Pumping to Percutaneous Cardiopulmonary Support Using Perclose ProGlide

Ziyad M. Hijazi, MD, FSCAI, FACC

Successful Retrieval of an Embolized Vascular Closure Device (Angio-Seal Ò ) After Peripheral Angioplasty

Peripheral and Cardiology Coder 2018

Evaluating the economic value of 5F systems for outpatients

Ziyad M. Hijazi, M.D., MPH, FSCAI, FACC

2 Brigham and Women s Hospital, Boston, MA.

Percutaneous Access for TEVAR

For Personal Use. Copyright HMP 2013

Thrombin injection vs Conventional Surgical Repair in Treatment of Iatrogenic Post-cath Femoral Artery Pseudoaneurysm (IFAP)

ANGIOPLASTY SUMMIT 2004 Seoul, South Korea APRIL 29-MAY 2, 2004

Vascular injury from an arterial closure device

(EU), FACC (USA), FSCAI (USA)

Άγγελος Παπανικολάου MD, Ειδικευόμενος Καρδιολογίας, A Πανεπιστημιακή Καρδιολογική Κλινική, ΓΝΑ Ιπποκράτειο

My personal experience with INCRAFT in standard and challenging cases

Percutaneous Transapical Access for Thoracic Endovascular Repair

Left ventricular guidewire pacing for transcatheter aortic valve. implantation

Transcatheter Aortic Valve Implantation Procedure (TAVI)

2019 ABBOTT REIMBURSEMENT GUIDE CMS Physician Fee Schedule

Diagnostic & Therapeutic Cardiac Catheterization Coder 2017

Prevention and Management of Vascular Complications Related to Transcatheter Aortic Valve Implantation

The common femoral artery remains the most commonly

Access (Antegrade, Retrograde, Pedal)

Percutaneous atrial septal defect closure with the Occlutech Figulla Flex ASD Occluder.

Quick Reference Guide

New Fully Absorbable Patch Based Large Hole Vascular Closure Device

Dr. Jean-Claude Laborde

Percutaneous Axillary Artery Access For Branch Grafting for complex TAAAs and pararenal AAAs: How to do it safely

Maximise Clinical Safety*. Cordis ExoSeal. The novel approach to secure and easy closure. Vascular Closure Device CORDIS EXOSEAL VCD

The CardioMEMS HF system (Abbott Vascular,

Ganapathy Ananthakrishnan, Richard D. White, Rajesh Bhat, and Sam Chakraverty

REDUCE COMPLICATIONS WITH RADIAL AND FEMORAL

Introduction What Causes Peripheral Vascular Disease? How Do Doctors Treat Peripheral Vascular Disease?... 9

Access site management with vascular closure devices for percutaneous transarterial procedures

Acute dissections of the descending thoracic aorta (Debakey

Access site management after transcatheter

Malperfusion Syndromes Type B Aortic Dissection with Malperfusion

Transcatheter Aortic Valve Replacement (TAVR)

The advent of transcatheter aortic valve implantation. Vascular Complications Among Patients. cover story

Vascular complications of embolized core valve

Management of Subclavian Arterial Injuries following Inadvertent Arterial Puncture during Central Venous Catheter Placement

Access Site Complications. Nick Cheshire MD FRCS, Professor of Vascular Surgery Imperial College Healthcare St Mary s Hospital Campus

MAXIMIZE RADIAL SOLUTIONS TO PERIPHERAL CHALLENGES

Cordis ExoSeal. Maximise Clinical Safety*. The novel approach to secure and easy closure. Vascular Closure Device CORDIS EXOSEAL VCD

The catheter-based treatment of valvular disease and aortic

Stenting of the Superior Vena Cava and Left Brachiocephalic Vein with Preserving the Central Venous Catheter in Situ

Port Design. Page 1. Port Placement, Removal, and Management. Selecting a Vascular Access Device. Thomas M. Vesely, MD

PERFORMANCE YOU CAN TRUST. EverFlex Self-expanding Peripheral Stent with Entrust Delivery System

Coding Changes for 2018

Ascending Aorta: Is The Endovascular Approach Realistic?

AV ACESS COMPLICATIONS. Ass. Prof. Dr. Habas

Index. interventional.theclinics.com. Note: Page numbers of article titles are in boldface type.

Sample page. POWER UP YOUR CODING with Optum360, your trusted coding partner for 32 years. Visit optum360coding.com.

AMPLATZER Septal Occluder Structural Heart Therapy. Over 15 years of. Demonstrated. Clinical Experience. We ll show you our data. Ask to see theirs.

Successful Transfemoral Edwards Sapien Aortic. Valve Implantation in a Patient with Previous. Mitral Valve Replacement

CY2017 Hospital Outpatient: Vascular Procedure APCs and Complexity Adjustments

Minimalist Transcatheter Aortic Valve Replacement (MA-TAVR)

Closure Devices. Peter F Ludman Advanced Angioplasty 2003

CY2015 Hospital Outpatient: Endovascular Procedure APCs and Complexity Adjustments

Introduction 3. What is Peripheral Vascular Disease? 5. What Are Some of the Symptoms of Peripheral Vascular Disease? 6

Ping-Pong Guide Catheter Technique for Retrograde Intervention of a Chronic Total Occlusion Through an Ipsilateral Collateral

Transcatheter Aortic Valve Replacement: Current and Future Devices: How do They Work, Eligibility, Review of Data

RadRx Your Prescription for Accurate Coding & Reimbursement Copyright All Rights Reserved.

TAVI Summit Eberhard Grube MD FACC, FSCAI Universitätsklinik Bonn, Medizinische Klinik und Poliklinik II, Bonn, Germany

Transcatheter closure of the patent ductus arteriosus using the new Amplatzer duct occluder: Initial clinical applications in children

Percutaneous Intervention for totally Occluded Coarctation Of Aorta. John Jose, Vipin Kumar, Ommen K George Dept Of Cardiology

Curtiss T. Stinis, M.D., F.A.C.C., F.S.C.A.I. SCRIPPS CLINIC

Transcription:

Open Journal of Clinical & Medical Case Reports Volume 1 (2015) Issue 1 Use of the Perclose ProGlide Closure Device to Remove a Central Venous Catheter Inadvertently Inserted in the Right Subclavian Artery Dr. Arturo Giordano Cardiovascular Interventions Unit, Pineta Grande Hospital, Domiziana Street KM 30, 81030 Castel Volturno CE, Italy Phone/Fax: +39-336-945902. Email: arturogiordano@tin.it Abstract Open Access Central venous access is commonly adopted in sick patients requiring intensive management. The insertion and management of central venous catheters (CVC) in the subclavian vein is usually safe and feasible in experienced hands, but complications may occur, especially in subjects with anatomical variants or when CVC have to be deployed in a hurry. An uncommon but potentially serious complication is the deployment of a CVC in the subclavian artery, as removal and hemostasis may prove challenging given the deep seating of the arteriotomy. We hereby report the case of a patient in whom a CVC had been inadvertently deployed in the right subclavian artery. Given the many comorbidities, a minimally invasive removal and hemostasis approach was attempted, using a Perclose ProGlide to seal the arteriotomy and concomitant intravascular balloon occlusion to ensure complete and timely hemostasis. This clinical vignette highlights the importance of mastering different skills and combining different devices to ensure the optimal management of vascular complications. Keywords Central venous catheter; Perclose Proglide; Right subclavian artery; Vascular closure device Introduction Improved life expectancy and re ined means for intensive care have lead to an exponential increase in the number of patients receiving central venous catheters (CVC) for diagnostic or therapeutic purposes. The typical access sites for CVC are the internal jugular and subclavian veins, with the subclavian vein being considered safer for long-term CVC use, but requiring more technical skills for successful puncture. Indeed, the complications of subclavian vein access may include hematoma, pneumothorax, hemothorax, nerve injury, and arterio-venous istula.(1) Another complication is the Open J Clin Med Case Rep: Volume 1 (2015) Giordano A et al

inadvertent deployment of the CVC in the subclavian artery. This occurrence may lead to life-threatening complications if drugs with potential for limb injury are administered. Even if this is not the case, removal of a CVC from a subclavian artery may prove challenging if open surgical repair is contraindicated in light of patient comorbidities, given the deep seating of this vessel and the complex anatomical relationship between this vessel and the lung, the clavicle, and the ribs. When a CVC has been inadvertently deployed in the subclavian artery, use of a vascular closure device may lead to successful and safe hemostasis, as long as the risk of failure is minimized or its potential consequences amended.(2-3) We hereby report a case of successful use of the Perclose ProGlide suture-based vascular closure device (Abbott Vascular, Santa Clara, CA, USA) to remove a central venous catheter inadvertently inserted in the right subclavian artery, with concomitant vessel protection with an intravascular balloon. Case Presentation A 70-year-old gentleman was referred to our institution after having received a CVC for the management of acute pulmonary edema and suspected endocarditis, as soon as the referring physician recognized that the CVC had not been deployed in the right subclavian vein, as intended, but inadvertently in the right subclavian artery (Figure 1). His medical history was notable for arterial hypertension and family history of coronary artery disease. He had also undergone surgical aortic valve replacement for severe aortic stenosis when he was 50 years old, with a Bicarbon 23 valve (Sorin, Saluggia, Italy). Given a subsequent worsening in left ventricular systolic function and widening of the QRS, he had then been implanted with an automated implantable cardioverter de ibrillator/cardiac resynchronization therapy (AICD/CRT) device. Despite this, he had suffered from several bouts of sustained ventricular tachycardia, requiring in the years preceding the index admission three separate left ventricular ablation procedures. A few days before being transferred to our institution he had suffered from severe shortness of breath, requiring hospital admission in another hospital. During such admission, a diagnosis of acute pulmonary edema and suspected endocarditis had been made, and an attempt to deploy a CVC in the right subclavian vein had been made. However, pressure readings from the deployed CVC had shown that the right subclavian artery had been punctured instead. After deploying, this time correctly, another CVC in the right jugular vein, the patient was referred to us for the removal of the CVC. In light of the patient comorbidities and our extensive experience with the management of challenging vascular access sites, we opted for a minimally invasive approach. We accessed the right Citation: Open Use J Clin of Med the Perclose Case Rep: Proglide Volume Clos 1 (2015) Page 2

femoral artery with a short 6 French sheath. Then, we performed selective angiography of the right subclavian artery and deployed a 0.018 Emerald guidewire (Cordis, Miami Lakes, FL, USA), with subsequent deployment over such guidewire of a 7.0x40 mm Senri balloon (Terumo, Tokyo, Japan). Keeping the balloon unin lated to avoid entanglements, we deployed over a 0.035 Emerald guidewire (Cordis) a Perclose ProGlide 6 French suture-mediated closure system. After knot pushing and suture trimming with the proprietary accessory, further knot pushing was performed with a straight Kocher hemostat, concomitantly in lating inside the right subclavian artery the Senri balloon at 16 atmospheres for 5 minutes. After removal of the straight Kocher hemostat and balloon de lation, the inal angiographic control disclosed adequate hemostasis, without any hematoma at skin inspection. The patient was then admitted to the stepdown medical care unit with an uneventful subsequent clinical stay. Discussion The exponential uptake of means for intravascular access has increased the treatment opportunities in intensively cared patients, but has also increased the risk of complications or untoward adverse events.(1) An uncommon but dif icult to manage complication is represented by the inadvertent puncture and deployment of the CVC into an arterial rather than a venous vessel. While surgical repair can always be envisioned in such cases, it may be associated with additional complications, especially in subjects with severe or multiple comorbidities. The use of vascular closure devices has improved the management of diagnostic and therapeutic procedures requiring arterial access, by providing a safe and time-saving means to achieve hemostasis even in the context of ongoing anticoagulation.(4) Indeed, vascular closure devices appear particularly promising to manage large bore arteriotomies, or arterial access in sites which may be challenging to reach surgically.(5-6) Accordingly, the use of vascular closure device to enable safe and effective removal of a CVC which has been inadvertently deployed in an artery has been already proposed in a number of reports.(2-3) We hereby expand the evidence base on this topic highlighting the promising role of the Perclose ProGlide suture-based closure device for a CVC which has been inadvertently deployed in the right subclavian artery, especially when combined with a simultaneous additional arterial access for bail-out purposes and for temporary intravascular balloon occlusion. Indeed, an updated analysis of the evidence base on this topic highlights several dozens of case reports are available on vascular closure device implantation for willing or inadvertent subclavian artery access, though most focus on the Angio-Seal collagen-plug Open J Clin Med Case Reports: Volume 1 (2015) Page 3

device (St. Jude Medical, Saint Paul, MN, USA), and only a few on the Perclose ProGlide. While operators experienced with subclavian access and vascular closure devices might think this is not a novel case, most operators are not experienced in subclavian access, in vascular closure devices, and in their combination. Accordingly, our case may represent an incrementally useful addition to the current body of data on vascular closure devices for subclavian artery access. In light of our extensive experience with the Perclose ProGlide for transfemoral aortic valve replacement (TAVR), we chose this speci ic device in this scenario, but other devices could have been envisioned.(7-8) Yet, using collagen-plug devices such as Angio-Seal or Exoseal (Cordis), could lead to a potential risk of cerebral embolization in this speci ic setting, potentially contraindicating their selection. In conclusion, the Perclose ProGlide suture-based vascular closure device can be successfully used to remove a central venous catheter inadvertently inserted in the right subclavian artery, especially when combined with concomitant vessel protection with an intravascular balloon. Figures Figure 1. Use of the Perclose ProGlide closure device to remove a central venous catheter inadvertently inserted in the right subclavian artery. Panel A. Fluoroscopy showing the position of the central venous catheter inadvertently deployed in the right subclavian artery (arrow), with concomitant presence of another central venous catheter in the right internal jugular vein (arrowhead). Panel B. Angiography showing the site of insertion of the central venous catheter in the right subclavian artery Citation: Open Use J Clin of Med the Perclose Case Rep: Proglide Volume Clos 1 (2015) Page 4

Panel C. Deployment of a 0.035 guidewire in the aortic root to enable the stable insertion of the Perclose ProGlide device. Panel D. Deployment of the Perclose ProGlide device with simultaneous intravascular protection with an unin lated 7.0x40 mm Senri balloon. Panel E. Prolonged in lation of the 7.0x40 mm Senri balloon with simultaneous knot pushing and external vessel compression with a straight Kocher hemostat. Panel F: Final angiography showing complete closure of the arteriotomy. References 1. Bowdle A. Vascular complications of central venous catheter placement: evidence-based methods for prevention and treatment. J Cardiothorac Vasc Anesth. 2014; 28: 358-368. 2. Berlet MH, Steffen D, Shaughness G, Hanner J. Closure using a surgical closure device of inadvertent subclavian artery punctures during central venous catheter placement. Cardiovasc Intervent Radiol. 2001; 24: 122-124. Open J Clin Med Case Reports: Volume 1 (2015) Page 5

3. Meyhoefer J, Lehmann H, Minden HH, Butter C. Closure of the subclavian artery puncture site with a percutaneous suture device after removal of an arterial pacemaker lead. Europace. 2006; 8: 1070-1072. 4. Byrne RA, Cassese S, Linhardt M, Kastrati A. Vascular access and closure in coronary angiography and percutaneous intervention. Nat Rev Cardiol. 2013; 10: 27-40. 5. Kim TH, Shim WH. Postclose technique for large sheath arterial access using perclose(tm) in emergency endovascular repair. Catheter Cardiovasc Interv. 2014; 83: 1176-1179. 6. Scha fer U, Ho Y, Frerker C, Schewel D, Sanchez-Quintana D, Schofer J, Bijuklic K, Meincke F, Thielsen T, Kreidel F, Kuck KH. Direct percutaneous access technique for transaxillary transcatheter aortic valve implantation: "the Hamburg Sankt Georg approach". JACC Cardiovasc Interv. 2012; 5: 477-486. 7. Biondi-Zoccai GG, Fusaro M, Tashani A, Mollichelli N, Medda M, De Giacobbi G, et al. Angioseal use after antegrade femoral arteriotomy in patients undergoing percutaneous revascularization for critical limb ischemia: a case series. Int J Cardiol. 2007; 118: 398-399. 8. Biondi-Zoccai G, Peruzzi M, Frati G. Use of the 8-f angio-seal vascular closure device for much larger sheaths: successfully itting a square PEG into a round hole? J Endovasc Ther. 2012; 19: 501-503. Manuscript Information: Received: January 31, 2015; Accepted: March 30, 2015; Published: April 06, 2015 1,2 1,2 1,2 1,2 3,4 Authors Information: Arturo Giordano, Nicola Corcione, Michele Polimeno, Stefano Messina, Giuseppe Biondi-Zoccai, 3 1,2 Antonino G. M. Marullo, Paolo Ferraro 1 Cardiovascular Interventions Unit, Pineta Grande Hospital, Castel Volturno, Italy 2 Operative Unit of Hemodynamics, St. Lucia Hospital, San Giuseppe Vesuviano, Italy 3 Department of Medical and Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy 4 Eleonora Lorillard Spencer Cenci Foundation, Rome, Italy Citation: Giordano et al. Use of the perclose proglide closure device to remove a central venous catheter inadvertently inserted in the right subclavian artery. Open J Clin Med Case Rep. 2015; 1001 Copy right Statement: Content published in the journal follows Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0). Giordano A et al Journal: Open Journal of Clinical and Medical Case Reports is an international, open access, peer reviewed Journal mainly focused exclusively on the medical and clinical case reports. Visit the journal website at www.jclinmedcasereports.com Open J Clin Med Case Reports: Volume 1 (2015) Page 6